AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback